Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ARS Pharmaceuticals (SPRY) Return on Assets (2021 - 2025)

ARS Pharmaceuticals (SPRY) has disclosed Return on Assets for 5 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 11.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, down 11.0% year-over-year, with the annual reading at 0.5% for FY2025, 50.0% down from the prior year.
  • Return on Assets hit 0.1% in Q4 2025 for ARS Pharmaceuticals, up from 0.25% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.09% in Q3 2022 to a low of 0.29% in Q3 2023.
  • Historically, Return on Assets has averaged 0.09% across 5 years, with a median of 0.07% in 2025.
  • Biggest five-year swings in Return on Assets: plummeted -38bps in 2023 and later grew 27bps in 2024.
  • Year by year, Return on Assets stood at 0.09% in 2021, then crashed by -37bps to 0.13% in 2022, then surged by 63bps to 0.05% in 2023, then soared by 113bps to 0.01% in 2024, then crashed by -1779bps to 0.1% in 2025.
  • Business Quant data shows Return on Assets for SPRY at 0.1% in Q4 2025, 0.25% in Q3 2025, and 0.17% in Q2 2025.